Skip to main content

Table 3 Distribution of genotypes of the studied CTLA4 polymorphisms1

From: The CTLA4 variants may interact with the IL23R- and NOD2-conferred risk in development of Crohn's disease

Variants

Genotype frequency

cases n = 333, controls n = 482

Dominant model2

Log-additive model2

rs736611

T/T

T/C

C/C

Genotype T/C + C/C

Allele C

CD

37%

48%

15%

63%

39%

Controls

34%

48%

18%

66%

42%

OR (95%CI)

   

0.89 (0.67 - 1.19)

0.86 (0.70 - 1.05)

g.49A > G (rs231775)

A/A

A/G

G/G

Genotype A/G + G/G

Allele G

CD

41%

46%

13%

59%

36%

Controls

40%

44%

16%

61%

38%

OR (95%CI)

   

0.85 (0.63 - 1.14)

0.89 (0.72 - 1.09)

CT60 (rs3087243)

G/G

G/A

A/A

Genotype G/A + A/A

Allele A

CD

33%

48%

19%

68%

43%

Controls

35%

48%

17%

65%

41%

OR (95%CI)

   

1.11 (0.82 - 1.50)

1.10 (0.90 - 1.35)

JO31 (rs11571302)

G/G

G/T

T/T

Genotype G/T + T/T

Allele T

CD

29%

50%

21%

71%

46%

Controls

31%

49%

20%

69%

44%

OR (95%CI)

   

1.12 (0.82 - 1.53)

1.09 (0.89 - 1.34)

JO27-1 (rs11571297)

A/A

A/G

G/G

Genotype A/G + G/G

Allele G

CD

29%

49%

22%

72%

47%

Controls

30%

50%

20%

70%

45%

OR (95%CI)

   

1.12 (0.82 - 1.53)

1.11 (0.91 - 1.36)

  1. 1: the rs1427676 polymorphism was excluded from the analyses as its distribution among healthy population did not conform to Hardy - Weinberg equilibrium.
  2. 2: Adjusted by gender